David A. Roth
2015 - Infinity Pharmaceuticals
In 2015, David A. Roth earned a total compensation of $1.6M as Chief Medical Officer at Infinity Pharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Option Awards | $838,627 |
| Salary | $292,692 |
| Other | $254,193 |
| Total | $1,635,512 |
Roth received $838.6K in option awards, accounting for 51% of the total pay in 2015.
Roth also received $250K in bonus, $292.7K in salary and $254.2K in other compensation.
Rankings
In 2015, David A. Roth's compensation ranked 5,569th out of 13,638 executives tracked by ExecPay. In other words, Roth earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,569 out of 13,638 | 59th |
Division Manufacturing | 2,061 out of 5,187 | 60th |
Major group Chemicals And Allied Products | 745 out of 1,857 | 60th |
Industry group Drugs | 591 out of 1,531 | 61st |
Industry Pharmaceutical Preparations | 463 out of 1,179 | 61st |
Source: SEC filing on April 25, 2016.
Roth's colleagues
We found five more compensation records of executives who worked with David A. Roth at Infinity Pharmaceuticals in 2015.
2015
Adelene Perkins
Infinity Pharmaceuticals
Chief Executive Officer
2015
Sujay Kango
Infinity Pharmaceuticals
Chief Commercial Officer
2015
Julian Adams
Infinity Pharmaceuticals
President of R&D
2015
Lawrence Bloch
Infinity Pharmaceuticals
Chief Financial Officer
2015
Vito Palombella
Infinity Pharmaceuticals
Chief Scientific Officer
News
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019